Figure 2From: Bezafibrate improves postprandial hypertriglyceridemia and associated endothelial dysfunction in patients with metabolic syndrome: a randomized crossover studyPostprandial changes in % FMD after the cookie test in the control and bezafibrate groups (A) and the relative maximum change in % FMD (B). Data are expressed as mean ± SE. *p < 0.05 vs. control group.Back to article page